ATM antibody
Cat.#: 1549-1
Rabbit Monoclonal Antibody
Clone ID: Y170
Swiss Prot: Q13315
Mol Weight: 370kDa
Size: 100ul
Description
ATM is a nuclear phosphoprotein involved in Ataxia-telangiectasia (A-T) an autosomal recessive disorder characterized by cerebellar ataxia, immune deficiencies, increased cancer predisposition, chromosomal instability and radiation sensitivity (1-2). This large protein (370 kDa) is involved in genome stability, cellular responses to DNA damage and cell cycle control. More than 100 mutations have been identified so far and are expected to inactivate the ATM protein by truncation or large deletions (3). Defects in ATM contribute to various B cell and T cell Leukemia (4).
Recommended Applications
WB, IHC, ICC, IP
Applications and Recommended Dilution Factors
WB: 1:1,000 - 10,000
IHC: 1:100-250
ICC: 1:100-250
IP: 1:50
Species Reactivity
Human
For Mouse, this antibody is recommended for WB only
Rat cross reactivity tested by western blot only
Products Data
![]() |
![]() |
![]() |
Specificity
A synthetic peptide corresponding to residues surrounding Serine 1981 of human ATM was used as immunogen.
Storage Condition and Buffer
Store at -20 °C. Buffer: 50 mM Tris-Glycine (pH 7.4), 0.15 M NaCl, 40% Glycerol, 0.01% sodium azide and 0.05% BSA. Stable for 12 months from date of receipt.
Alternative Names
ATM antibody, AT1 antibody, ATA antibody, ATC antibody, ATD antibody, ATDC antibody, ATE antibody, DKFZp781A0353 antibody, MGC74674 antibody, TEL1 antibody, TELO1 antibody, Serine-protein kinase ATM antibody, Ataxia telangiectasia mutated antibody
Description References
1. Harnden, D.G. (1994) Int. J. Radiat. Biol. 66, S13-S19
2. Lavin, M.F. and Shiloh, Y. (1997) Ann. Rev. Immunol. 15, 177-202
3. Savitsky, K., Sfez, S., Tagle, D.A., Ziv, Y., Sartiel, A., Collins, F.S., Shiloh, Y. and Rotman, G. (1995) Hum. Mol. Gen. 4, 2025-2032.
4. Stankovic T., Weber P., Stewart G., Bedenham T., Murray J., Byrd P.J., Moss P.A.H., Taylor A.M.R.; Lancet 353:26-29(1999).
Product References
1. Gorodetsky E, Calkins S , Ahn J, et al, ATM, the Mre11/Rad50/Nbs1 complex, and topoisomerase I are concentrated in the nucleus of Purkinje neurons in the juvenile human brain ,DNA repair 6 ( 2007 ) 1698–1707
[Application: ICC]
2. Bitona S, Gropp M, Itsyksonb P, et al, ATM-mediated response to DNA double strand breaks in human neurons derived from stem cells ,DNA repair 6 (2007) 128–134
[Application: ICC]
3. Li H, Baskaran R, Krisky DM, et al, Chk2 is required for HSV-1 ICP0-mediated G2/M arrest and enhancement of virus growth ,Virology 375 (2008) 13–23
[Application: WB]
4. Schwartz RA, Carson CT, Schuberth C, et al, Adeno-Associated Virus Replication Induces a DNA Damage Response Coordinated by DNA-Dependent Protein Kinase ,J. Virol. 83 (2009) 6269 -6278
[Application: IP]
5. Lakdawala SS, Schwartz RA, Ferenchak K, et al, Differential Requirements of the C Terminus of Nbs1 in Suppressing Adenovirus DNA Replication and Promoting Concatemer Formation ,Journal of Virology 82 (2008) 8362–8372
[Application: WB]
6. Biton S, Dar I, Mittelman L, et al, Nuclear Ataxia-Telangiectasia Mutated (ATM) Mediates the Cellular Response to DNA Double Strand Breaks in Human Neuron-like Cells ,The Journal of Biological Chemistry 281 (2006) 17482–17491
[Application: ICC]
7. Cheng WH, Muftic D, Muftuoglu M, et al, WRN is required for ATM activation and the S-phase checkpoint in response to interstrand crosslink-induced DNA double strand breaks ,Mol. Biol. Cell 19 (2008) 3923 - 3933
[Application: WB, ICC]
8. Togano T, Sasaki M, Watanabe M, et al, Induction of oncogene addiction shift to NF-κB by camptothecin in solid tumor cells ,Biochem Biophys Res Commun 390 (2009) 60-64
[Application: WB]
9. Wu M, Kang MM, Schoene NW, et al, Selenium Compounds Activate Early Barriers of Tumorigenesis ,J Biol Chem 285 (2010) 12055-12062
10. Boichuk S, Hu L, Hein J, et al, Multiple DNA Damage Signaling and Repair Pathways Deregulated by Simian Virus 40 Large T Antigen ,J Virol 84 (2010) 8007-8020
11. Qi Y, Schoene NW, Lartey FM, et al, Selenium Compounds Activate ATM-dependent DNA Damage Response via the Mismatch Repair Protein hMLH1 in Colorectal Cancer Cells ,J Biol Chem 285 (2010) 33010-33017
更多
企业名称
上海希美化学有限公司
企业信息已认证
企业类型
信用代码
310228001203103
成立日期
2009-05-31
注册资本
10
经营范围
化工原料及产品(除危险化学品、监控化学品、烟花爆竹、民用爆炸物品、易制毒化学品),实验室设备,仪器仪表,金属制品,电子产品,机电产品销售,从事化工科技、计算机科技领域内技术开发、技术咨询、技术服务。【依法须经批准的项目,经相关部门批准后方可开展经营活动】
上海希美化学有限公司
公司地址
上海市松江区陆家圈路168弄113号
客服电话